LGX818 for Patients With BRAFV600 Mutated Tumors
Clinical trial NCT01981187 · TERMINATED
Trial details
- NCT number
- NCT01981187
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-14
- Primary completion
- 2015-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.